MOST NOTEWORTHY:

• Merriman believes GSI Technology Inc (NASDAQ: GSIT) is positioned to benefit as growing bandwidth demand and increasingly complex protocols drive the need for faster and higher density memory in networking equipment. The firm started shares with a Buy rating.
• Array Biopharma Inc (NASDAQ: ARRY) was assumed with an Outperform rating at William Blair. The firm thinks the company's pipeline contains significant value, which will be catalyzed over the next 12-18 months by continued clinical progress and potential partnerships.
• Continental Resources Inc (NYSE: CLR) was initiated with a Buy rating and $30 target at Jefferies, and points to the company's double-digit growth and strong reserve growth potential.

• Lehman initiated Ventas Inc (NYSE: VTR) with an Equal Weight rating $46 target and HCP Inc (NYSE: HCP) with an Overweight rating.
• The Boston Beer Company Inc (NYSE: SAM) was assumed with an Overweight rating and $43 target at HSBC.

Analyst initiations: GSIT, ARRY and CLR originally appeared on BloggingStocks on Thu, 07 Feb 2008 10:18:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY: The Small Cap BioTech sector top today's small list of initiations.

• The Bank of America initiated five companies within the Small Cap BioTech sector:
• Myriad Genetics, Inc. (NASDAQ:MYGN), Array BioPharma, Inc. (NASDAQ:ARRY), Nuvelo, Inc. (NASDAQ:NUVO) and Keryx BioPharmaceuticals Inc (NASDAQ:KERX) with Buy ratings
• and Dendreon Corp (NASDAQ:DNDN) with a Neutral rating.

OTHER INITIATIONS:

• Fiserv, Inc. (NASDAQ:FISV) was resumed with a Market Perform at Wachovia on valuation
• and Century Casinos, Inc. (NASDAQ:CNTY) was initiated with a Hold at Morgan Joseph on valuation.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst initiations 11-2-06: Small Cap BioTech sector initiated originally appeared on BloggingStocks on Thu, 02 Nov 2006 12:14:00 EST. Please see our terms for use of feeds.